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RNA editingAbstract Scientists theorized that b-amyloid (Ab) plaques and tau tangles are involved in the
development of Alzheimer’s disease (AD), and amyloid precursor protein (APP) produces Ab to trig-
ger the disease process. However, the normal synaptic function of APP itself is not fully understood.
Several ﬁndings cast APP as a potential key player in learning and memory under normal condition.
Nevertheless, the regular operation of APP will be disrupted by abnormal accumulation of Ab under
cellular pathological conditions. Herein, there is a hypothesis that AD could be treated by attenuat-
ing APP synthesis during cellular pathophysiological stress. In virtue of a previous study, it was
speculated that cells could not decrease APP synthesis via self-protection maybe because APP is
synthesized via internal ribosome entry segment (IRES)-mediated translation. Consequently, the
blockage of this translation might be a new inoffensive and high-level speciﬁcity treatment.
ª 2014 Tehran University of Medical Sciences. Published by Elsevier Ltd. All rights reserved.Introduction
Ab and APP
Alzheimer’s disease (AD) is a neurodegenerative disorder char-
acterized by the presence of aggregates of b-amyloid (Ab) and
intraneuronal neuroﬁbrillary tangles (NFTs) with tau protein
[1]. Therefore, there are usually two typical pathological
hallmarks in AD patient brain: First, Ab plaques outside of
neurons are produced via the accumulation of Ab, and then
NFTs inside them are formed via tau protein phosphorylation.In addition, the NFTs mostly occur after Ab plaques have
developed. It is believed that Ab plaques ignite the fuse to trig-
ger the disease process. Furthermore, Ab is derived from amy-
loid precursor protein (APP) via two proteases, b-secretase and
c-secretase [2]. Notwithstanding, the normal functions of
uncleaved APP in the brain are still unknown, a few studies
also suggested that full-length APP with nonamyloidogenic
pathway as a potential key player in learning and memory
through the promotion of synaptic activity, synapse forma-
tion, and dendritic spine formation [3–6]. In addition, Ma
and colleagues found further that Ab levels exceeding the
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[7]. Therefore, there is a premise that a certain amount of
Ab is required for physiological function regulations in the
neurons. However, under pathological stress conditions, the
increase in Ab concentration produces pathological effects,
including decreased presynaptic neurotransmitter release,
reduced postsynaptic responsiveness, long-term potentiation
(LTP) impairment, and long-term depression (LTD) facilita-
tion (see Ref. [8] for a recent review). As a result, the concen-
tration of Ab (APP) must be maintained within a normal
physiological range in order to treating AD.
IRES-mediated translation
The majority of mRNAs in eukaryotic cells are translated via
the methylguanosine cap at the 50 end of the mRNA with
eukaryotic initiation factors (eIFs). In general, many of the
eIFs (eIF2a, eIF4GI, eIF4GII, eIF3j) involved in this process
are degraded and become less active under a number of patho-
physiological stress conditions or apoptosis, thus attenuating
protein synthesis [9]. Scientists subsequently found that a num-
ber of proteins (e.g., XIAP, c-Myc, and DAP5), involved in cell
death, are still synthesized via cap-independent translation dur-
ing apoptosis [10–12]. The initiation of cap-independent trans-
lation involved a complex RNA structural element known as
internal ribosome entry segment (IRES) to recruit ribosomes
[13–15]. This structural element in the 50-untranslated region
(UTR) plays a pivotal role in cell’s relieving and recovery from
stress condition as usual. As we know, eIF2a phosphorylation
will increase under cell death, but how can the IRES-dependent
translation bypass the limitation of protein synthesis such as
eIF2a phosphorylation under physiological and pathophysio-
logical stress? With respect to this new challenge, scientists pro-
posed some meaningful hypothesis [16]. On the basis of a few
eIF2-independent modes of translation of viral RNAs [17,18],
recently, Nehal Thakor and Martin Holcik have theorized that
the IRES-mediated translation of X-linked inhibitor of apopto-
sis protein (XIAP) is more likely to be dependent upon eIF2a
during normal growth condition and then switches to
eIF5B-dependent mode when eIF2a is phosphorylated under
cellular stress. Interestingly, these results cater for previous
hypothesis, however, they also noticed that not all cellular
IRES operate with an eIF5B-dependent mode [19].
APP and IRES-dependent translation
Salubrinal, an inhibitor of eIF2a-P dephosphorylation, is used
for inducing eIF2a phosphorylation to promote cell survival
under endoplasmic reticulum (ER) stress [20]. Although some
groups tried to treat AD by altering the level of eIF2a phos-
phorylation using salubrinal [21,22], the results were less effec-
tive than kainic acid injury-induced cell death [23] and cerebral
stroke [24]. As a result, it is suggested that the short-term treat-
ment of salubrinal, with no alterations in phosphorylated
eIF2a levels, protects against Ab neurotoxicity through inhibi-
tion of the NF-jB pathway rather than through inhibition of
ER stress. However, after long-term incubation (1 week) with
salubrinal, the eIF2a phosphorylation levels were markedly
higher following further repression of global translation and
reduction of synaptic proteins that resulted in severe neuronal
loss and signiﬁcantly accelerating disease. Herein, we canconclude that Ab-induced cell death has little correlation with
eIF2a phosphorylation level. In addition, Leslie A. Krushel
and coworkers found that APP could also be synthesized
through IRES-mediated translation. Besides, they suggested
that the APP 50-leader consists three regions including
5050 nt, the internal 44 nt and 3053 nt, furthermore, the region
of 5050 nt is sufﬁcient to internally initiate translation (i.e., this
region is sufﬁcient to exhibit IRES activity, although total
IRES activity was reduced by approximately half of the full-
length APP leader) [25]. Given all that, I suggested that this
kind of translation manner via eIF2a-independent mode can
make APP synthesis resistant to the limitation of cell respond
phosphorylating subunits of eIFs under ER stress or other
pathophysiological stress.
Proposal and evaluation of hypothesis
Hypothesis
In this article, I proposed two methods as a potential
treatment. A: RNA editing on 50 nt of the APP 50-UTR
[25]. B: Editing/removing the IERS element within longer
50-UTR [26].
Evaluation of hypothesis
First, there is a signiﬁcant necessity for research operation
mechanism of IERS-mediated translation of APP via avidin–
biotin RNA afﬁnity chromatography and additional biochem-
ical, molecular biological, and cell culture methods to ensure
the validity of the eIF2a-independent mode of APP synthesis
[19]. Subsequently, the effects of the two methods should be
tested by identifying apoptotic neurons and the viability of
the neurons. In order to verify successfully, the appropriate
infected cell mode and three experimental groups (A, B,
A + B) should be set. The two methods also should be tested
to know whether they inﬂuence traditional translation. In prac-
tice, method B should not be considered unless method A is
ineffectual. The intrinsic mechanisms of hypothesis: Under nor-
mal condition, if hypothesis make good, this kind of treatment
will not obstruct the normal levels synthesis of APP to keep
APP operate normal functions because the translations of
APP are conducted via traditional manner predominantly this
moment. On the other hand, under pathological stress condi-
tions, APP synthesis can be performed neither traditional trans-
lation (eIF2a-dependent manner) due to eIFs phosphorylation
and cleavage nor IRES-translation (eIF2a-independent man-
ner) because of lack IRES activity after treatment. In this
way, cell can attenuate synthesis of APP and then Ab to prevent
Ab concentration from exceeding the normal range (Fig. 1).
Discussion
The hypothesis in this article is a treatment method for AD by
controlling the IRES-mediated translation of APP intrinsi-
cally. In virtue of this rule, a few RNA-binding proteins
repressing IRES activity as potential treatments still lack
stability and reliability [27–29]. In addition, Martin Holcik
suggested that initiation complex formed on the XIAP IRES
RNA is indeed translation competent. Therefore, I also try
to explore targeting translation initiation factors such as eIF5B
Fig. 1 The diagram of operation mechanism, the blue lines mean
the eIF2a-dependent pathway and the red line means the eIF2a-
independent pathway. The effects of cellular stress trigger a
switch-like in circuit diagram, stopping the cap-independent
translation with only one route completely, however, do not
blocking IRES-independent translation due to the other route
(IRES-translation managers preferentially perform an eIf2a-
dependent under normal condition). Herein, the treatment aims
to cut the second route response to APP synthesis.
Second question: What does your proposed theory add
to the current knowledge available and what beneﬁts does
it have?
Although some studies focus on repressing IRES activity
as a potential treatment for AD via controlling a few
RNA-binding proteins, this method could still cause
potential damage for the whole cell due to lack of safety
and high-level speciﬁcity. If the theory in this article
proves to be effective, a safer way to treat AD would be
set.
Third question: Among numerous available studies, what
special further study is proposed for testing the idea?
In order to evaluate whether RNA editing is an effective
treatment for AD, ﬁrst, studies which focus on the
operation mechanism of IRES-mediated translation of
APP should be conducted. In the next stage, animal
testing (using mice) should be further designed. If encour-
aging results are shown, a study in humans should be
considered.
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translations of other proteins and even normal functions of
cells are easy to be inﬂuenced by lack of enough available
translation initiation factors. The treatment in hypothesis is
an effective solution of a goal that treatments should maintain
the concentration of Ab within a normal physiological range
proposed from the review above [8] and consider the high-level
speciﬁcity for target protein (APP in this article). Once
hypothesis make good, the nerve cells can be survived by
self-preservation phosphorylating subunits of eIFs. In this
way, treatments will have only minor side effect.Overview box
First Question: What do we already know about the
subject?
The amyloid precursor protein (APP) is most com-
monly known as the source of the Ab that accumulate in
the brains of patients withAlzheimer’s disease (AD). Scien-
tists found that nerve cells could not decrease APP synthe-
sis via self-protection under pathophysiological stress.
Most recently, it has been shown that APP synthesis may
be performed via a new translation mechanism called as
internal ribosome entry segment (IRES)-mediated transla-
tion. According to the results, IRES-mediated translation
allows proteins to continue translating via an eIF2a-inde-
pendent manner under pathophysiological stress.Conﬂict of interest
The authors report no conﬂicts of interest.
References
[1] Smith MA, Perry G. What are the facts and artifacts of the
pathogenesis and etiology of Alzheimer disease? J Chem
Neuroanat 1998;16:35–41.
[2] Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA,
Denis P, et al. Beta-secretase cleavage of Alzheimer’s amyloid
precursor protein by the transmembrane aspartic protease
BACE. Science 1999;286:735–41.
[3] Young-Pearse TL, Chen AC, Chang R, Marquez C, Selkoe DJ.
Secreted APP regulates the function of full-length APP in
neurite outgrowth through interaction with integrin beta1.
Neural Dev 2008;3:15.
[4] Gakhar-Koppole N, Hundeshagen P, Mandl C, Weyer SW,
Allinquant B, Muller U, et al. Activity requires soluble amyloid
precursor protein alpha to promote neurite outgrowth in neural
stem cell-derived neurons via activation of the MAPK pathway.
Eur J Neurosci 2008;28:871–82.
[5] Leyssen M, Ayaz D, Hebert SS, Reeve S, De Strooper B, Hassan
BA. Amyloid precursor protein promotes post-developmental
neurite arborization in the Drosophila brain. EMBO J
2005;24:2944–55.
[6] Hoe HS, Fu Z, Makarova A, Lee JY, Lu C, Feng L, et al. The
effects of amyloid precursor protein on postsynaptic
composition and activity. J Biol Chem 2009;284:8495–506.
[7] Ma T, Hoeffer CA, Wong H, Massaad CA, Zhou P, Iadecola C,
et al. Amyloid beta-induced impairments in hippocampal
synaptic plasticity are rescued by decreasing mitochondrial
superoxide. J Neuroscience 2011;31:5589–95.
[8] Wang H, Megill A, He K, Kirkwood A, Lee HK. Consequences
of inhibiting amyloid precursor protein processing enzymes on
synaptic function and plasticity. Neural Plast 2012;2012:272374.
[9] Clemens MJ, Bushell M, Jeffrey IW, Pain VM, Morley SJ.
Translation initiation factor modiﬁcations and the regulation of
60 Q.Y. Liuprotein synthesis in apoptotic cells. Cell Death Differ
2000;7:603–15.
[10] Stoneley M, Chappell SA, Jopling CL, Dickens M, MacFarlane
M, Willis AE. C-Myc protein synthesis is initiated from the
internal ribosome entry segment during apoptosis. Mol Cell Biol
2000;20:1162–9.
[11] Henis-Korenblit S, Strumpf NL, Goldstaub D, Kimchi A. A
novel form of DAP5 protein accumulates in apoptotic cells as a
result of caspase cleavage and internal ribosome entry site-
mediated translation. Mol Cell Biol 2000;20:496–506.
[12] Holcik M, Lefebvre C, Yeh C, Chow T, Korneluk RG. A new
internal-ribosome-entry-site motif potentiates XIAP-mediated
cytoprotection. Nat Cell Biol 1999;1:190–2.
[13] Hellen CU, Sarnow P. Internal ribosome entry sites in
eukaryotic mRNA molecules. Genes Dev 2001;15:1593–612.
[14] Komar AA, Hatzoglou M. Internal ribosome entry sites in
cellular mRNAs: mystery of their existence. J Biol Chem
2005;280:23425–8.
[15] Stoneley M, Willis AE. Cellular internal ribosome entry
segments: structures, trans-acting factors and regulation of
gene expression. Oncogene 2004;23:3200–7.
[16] Komar AA, Hatzoglou M. Cellular IRES-mediated translation:
the war of ITAFs in pathophysiological states. Cell Cycle
2011;10:229–40.
[17] Dmitriev SE, Terenin IM, Andreev DE, Ivanov PA, Dunaevsky
JE, Merrick WC, et al. GTP-independent tRNA delivery to the
ribosomal P-site by a novel eukaryotic translation factor. J Biol
Chem 2010;285:26779–87.
[18] Skabkin MA, Skabkina OV, Dhote V, Komar AA, Hellen CU,
Pestova TV. Activities of Ligatin and MCT-1/DENR in
eukaryotic translation initiation and ribosomal recycling.
Genes Dev 2010;24:1787–801.
[19] Thakor N, Holcik M. IRES-mediated translation of cellular
messenger RNA operates in eIF2alpha- independent manner
during stress. Nucleic Acids Res 2012;40:541–52.[20] Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner
D, et al. A selective inhibitor of eIF2alpha dephosphorylation
protects cells from ER stress. Science 2005;307:935–9.
[21] Moreno JA, Radford H, Peretti D, Steinert JR, Verity N,
Martin MG, et al. Sustained translational repression by
eIF2alpha-P mediates prion neurodegeneration. Nature
2012;485:507–11.
[22] Huang X, Chen Y, Zhang H, Ma Q, Zhang YW, Xu H.
Salubrinal attenuates beta-amyloid-induced neuronal death and
microglial activation by inhibition of the NF-kappaB pathway.
Neurobiol Aging 2012;33(1007):e9–17.
[23] Sokka AL, Putkonen N, Mudo G, Pryazhnikov E, Reijonen S,
Khiroug L, et al. Endoplasmic reticulum stress inhibition
protects against excitotoxic neuronal injury in the rat brain. J
Neurosci 2007;27:901–8.
[24] Nakka VP, Gusain A, Raghubir R. Endoplasmic reticulum
stress plays critical role in brain damage after cerebral ischemia/
reperfusion in rats. Neurotox Res 2010;17:189–202.
[25] Beaudoin ME, Poirel VJ, Krushel LA. Regulating amyloid
precursor protein synthesis through an internal ribosomal entry
site. Nucleic Acids Res 2008;36:6835–47.
[26] Riley A, Jordan LE, Holcik M. Distinct 50 UTRs regulate XIAP
expression under normal growth conditions and during cellular
stress. Nucleic Acids Res 2010;38:4665–74.
[27] Lin JY, Li ML, Shih SR. Far upstream element binding protein
2 interacts with enterovirus 71 internal ribosomal entry site and
negatively regulates viral translation. Nucleic Acids Res
2009;37:47–59.
[28] Pacheco A, Lopez de Quinto S, Ramajo J, Fernandez N,
Martinez-Salas E. A novel role for Gemin5 in mRNA
translation. Nucleic Acids Res 2009;37:582–90.
[29] Merrill MK, Dobrikova EY, Gromeier M. Cell-type-speciﬁc
repression of internal ribosome entry site activity by double-
stranded RNA-binding protein 76. J Virol 2006;80:3147–56.
